Resource Center

Find out more about the Cymbalta Promise Program, our commitment to support people taking Cymbalta.

Cymbalta is indicated for the treatment of major depressive disorder (MDD). The efficacy of Cymbalta was established in four short-term and one maintenance trial in adults.

Cymbalta is indicated for the treatment of generalized anxiety disorder (GAD). The efficacy of Cymbalta was established in three short-term and one maintenance trial in adults.

Cymbalta is indicated for the management of diabetic peripheral neuropathic pain and fibromyalgia.

Cymbalta is indicated for the management of chronic musculoskeletal pain due to chronic osteoarthritis pain and chronic low back pain.

Here are some resources to help you learn more about each of the following conditions:

Diabetic Nerve Pain

Diabetic Nerve Pain Treatment Initiation Guide

Fibromyalgia

Fibromyalgia Treatment Initiation Guide

Cymbalta Offers

Get a Free 30-Capsule Trial of Cymbalta
Cymbalta Promise Program